TABLE 1.
iELISA | Groupsa | Cutoff (RI)d | Sensitivity (95% CI) | Specificity (95% CI) | LR+e | LR−e |
---|---|---|---|---|---|---|
Anti-IgG-HRPOb | GI × GII | 56 | 82.9 (71.4-94.4) | 82.3 (73.9-90.7) | 4.7 | 0.274 |
GI × GIII | 40 | 97.6 (92.8-102.3) | 97.1 (93.9-100.3) | 33.7 | 0.025 | |
GI × GIV | 49 | 87.8 (77.8-97.8) | 89.2 (85.6-92.9) | 8.1 | 0.137 | |
Protein A-HRPOc | GI × GII | 38 | 80.5 (68.4-92.6) | 94.9 (90.1-99.8) | 15.8 | 0.205 |
GI × GIII | 20 | 97.6 (92.8-102.3) | 97.1 (94.0-100.3) | 33.7 | 0.025 | |
GI × GIV | 22 | 97.6 (92.8-102.3) | 94.6 (91.9-97.3) | 18.1 | 0.025 |
GI, nonvaccinated seropositive cows originated from areas where Brucella is endemic or an outbreak is occurring (n = 41); GII, S19-vaccinated heifers between 3 and 8 months of age, originated from areas where Brucella is endemic, and serum samples were analyzed at 3 months postvaccination (n = 79); GIII, S19-vaccinated cows between 3 and 8 months of age, originated from areas where Brucella is endemic, and serum samples were analyzed after 24 months of age (n = 105); GIV, nonvaccinated seronegative cows originated from areas where Brucella is nonendemic (n = 278).
iELISA using anti-bovine IgG labeled with peroxidase (HRPO) as conjugate.
iELISA using protein A-HRPO as conjugate.
Reactivity index (RI) = (mean OD sample/mean OD positive control) × 100.
LR+, positive likelihood ratio; LR−, negative likelihood ratio. The figures in bold indicate significant LR values.